| Cat. No. |
Product Name |
Information |
| PC-21272 |
PRT543
PRMT5 inhibitor
|
PRT543 is a highly potent, selective and SAM cpmpetitive inhibitor of protein arginine methyltransferase 5 (PRMT5) with IC50 of 10.8 nM. |
| PC-21078 |
METTL3 inhibitor 54
METTL3 inhibitor
|
METTL3 inhibitor 54 is a potent, selective inhibitor of m6A-RNA writer enzyme methyltransferase-like 3 (METTL3) with IC50 of 54 nM for METTL3/METTL14 in HTRF assays. |
| PC-21040 |
EPZ033294
SMYD2 inhibitor
|
EPZ033294 is a potent, selective inhibitor of SMYD2 with biochemical IC50 of 3.9 nM, and function of cellular methylation IC50 of 29 nM. |
| PC-21039 |
EPZ028862
SMYD3 inhibitor
|
EPZ028862 is a potent, selective inhibitor of SMYD3 with biochemical IC50 of 1.8 nM, and function of cellular methylation IC50 of 32 nM. |
| PC-21038 |
KTX-1001
NSD2 inhibitor
|
Gintemetostat (KTX-1001) is a potent, selective histone methyltransferase NSD2 (WHSC1, MMSET) inhibitor targeting the catalytic SET domain with IC50 of 2.32 nM. |
| PC-21013 |
EML1219
PRMT9 inhibitor
|
EML1219 is a selective small molecule inhibitor of protein arginine methyltransferase isoform PRMT9 with IC50 of 0.2 uM. |
| PC-21012 |
EML734
PRMT7/9 inhibitor
|
EML734 is a selective small molecule inhibitor of protein arginine methyltransferase isoforms, PRMT7 and PRMT9 with IC50 of 0.32 and 0.89 uM, respectively. |
| PC-20906 |
EPIC-0307
PRADX-EZH2 inhibitor
|
EPIC-0307 is a selective small-molecule inhibitor of PRADX-EZH2 interaction, inhibits GBM cell lines with IC50 of 12.13-17.69 uM, enhances temozolomide (TMZ) sensitivity to glioblastoma. |
| PC-20858 |
BBDDL2059
EZH2 inhibitor
|
BBDDL2059 (BBDDL 2059) is a potent, selective and covalent inhibitor of EZH2 with IC50 of 1.5 nM (EZH2-Y641F), targeting the Cys663 of EZH2. |
| PC-20857 |
CPI-1328
EZH2 inhibitor
|
CPI-1328 is a highly potent, selective EZH2 inhibitor with sub-pM binding affinitiy (Ki=63 fM). |
| PC-20832 |
SETDB1 activator (R,R)-59
SETDB1 activator
|
(R,R)-59 is a small-molecule ligand activator for methyltransferase SETDB1 Triple Tudor Domain (3TD reader domain) with binding IC50 of 1.2 uM in TR-FRET assays, specifically promotes in vitro SETDB1-mediated methylation of lysine 64 of protein kinase Akt1. |
| PC-20645 |
HKMTI-1-005
G9a/GLP/EZH2 inhibitor
|
HKMTI-1-005 is a potent, substrate-competitive dual inhibitor of EZH2 and the closely related G9a/GLP H3K9 methyltransferases with IC50 of 0.1 uM (EHMT2). |
